NCT04198467View on ClinicalTrials.gov

To Evaluate the Optimum Dose of Platelet Rich Plasma in Knee Osteoarthritis and Compare Efficacy With Hyaluronic Acid

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 21, 2014

Primary Completion Date

April 15, 2016

Study Completion Date

July 10, 2016

Conditions
Knee Osteoarthritis
Interventions
BIOLOGICAL

Platelet rich plasma

Platelet rich plasma : 100 billion platelets in 10 ml of plasma(PRP) administered intra-articular

DRUG

Hyaluronic Acid

Hyaluronic acid :Four ml of high-molecular-weight hyaluronic acid with a concentration of 22mg/ml injected intra-articular

All Listed Sponsors
lead

Dr. Himanshu Bansal Foundation

OTHER

NCT04198467 - To Evaluate the Optimum Dose of Platelet Rich Plasma in Knee Osteoarthritis and Compare Efficacy With Hyaluronic Acid | Biotech Hunter | Biotech Hunter